GILEAD SCIENCES, INC.

Insider Reports History

Location
Foster City, CA
Signature
Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GILEAD SCIENCES, INC.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcellx, Inc. 10%+ Owner Common Stock 6,720,803 $371,444,668 $55.27 28 Dec 2023 Direct
Arcus Biosciences, Inc. 10%+ Owner Common Stock 31,424,760 $345,672,360 $11.00 18 Feb 2025 Direct
ASSEMBLY BIOSCIENCES, INC. 10%+ Owner Common Stock 4,505,391 $100,290,003 $22.26 08 Aug 2025 Direct
Xilio Therapeutics, Inc. 10%+ Owner Prefunded Warrants (right to buy) 36,645,266 $27,480,284 $0.7499 26 Nov 2025 Direct
LEAP THERAPEUTICS, INC. 10%+ Owner Common Stock 5,319,148 $15,159,572 $2.85 10 Apr 2024 Direct
HOOKIPA Pharma Inc. 10%+ Owner Common Stock 18,759,465 $13,600,612 $0.7250 20 Dec 2023 Direct
Allovir, Inc. 10%+ Owner Common Stock 16,635,286 $11,158,950 $0.6708 27 Jun 2023 Direct
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 9,105,451 $9,469,669 $1.04 18 Dec 2024 Direct
Xilio Therapeutics, Inc. 10%+ Owner Series A Warrants (right to buy) 13,335,000 05 Jun 2025 Direct
Xilio Therapeutics, Inc. 10%+ Owner Series C Warrants (right to buy) 13,335,000 05 Jun 2025 Direct
Kyverna Therapeutics, Inc. 10%+ Owner Common Stock 4,126,119 12 Feb 2024 Direct
ASSEMBLY BIOSCIENCES, INC. 10%+ Owner Class A warrants to purchase Common Stock 1,147,960 08 Aug 2025 Direct
ASSEMBLY BIOSCIENCES, INC. 10%+ Owner Class B warrants to purchase Common Stock 1,147,960 08 Aug 2025 Direct
Kyverna Therapeutics, Inc. 10%+ Owner Series A-2 Convertible Preferred Stock 0 12 Feb 2024 Direct
Kyverna Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 12 Feb 2024 Direct
Xilio Therapeutics, Inc. 10%+ Owner Series B Warrants (right to buy) 0 26 Nov 2025 Direct

Insider Reports Filed by GILEAD SCIENCES, INC.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XLO Xilio Therapeutics, Inc. 26 Nov 2025 2 +$9,999,916 4 10%+ Owner 01 Dec 2025, 16:36
ASMB ASSEMBLY BIOSCIENCES, INC. 08 Aug 2025 3 $0 4 10%+ Owner 03 Oct 2025, 16:30
XLO Xilio Therapeutics, Inc. 05 Jun 2025 4 $0 4 10%+ Owner 06 Jun 2025, 19:31
RCUS Arcus Biosciences, Inc. 18 Feb 2025 1 +$14,999,996 4 10%+ Owner 20 Feb 2025, 19:42
ASMB ASSEMBLY BIOSCIENCES, INC. 19 Dec 2024 1 +$20,098,464 4 10%+ Owner 23 Dec 2024, 20:26
XLO Xilio Therapeutics, Inc. 18 Dec 2024 2 +$8,166,296 4 10%+ Owner 19 Dec 2024, 16:19
ASMB ASSEMBLY BIOSCIENCES, INC. 17 Jun 2024 2 $0 4 10%+ Owner 20 Jun 2024, 20:31
LPTX LEAP THERAPEUTICS, INC. 10 Apr 2024 0 $0 3 10%+ Owner 19 Apr 2024, 16:31
XLO Xilio Therapeutics, Inc. 02 Apr 2024 2 +$3,319,064 4 10%+ Owner 03 Apr 2024, 18:50
XLO Xilio Therapeutics, Inc. 27 Mar 2024 0 $0 3 10%+ Owner 03 Apr 2024, 18:48
KYTX Kyverna Therapeutics, Inc. 12 Feb 2024 4 +$20,020,000 4 10%+ Owner 13 Feb 2024, 17:48
KYTX Kyverna Therapeutics, Inc. 07 Feb 2024 0 $0 3 10%+ Owner 07 Feb 2024, 17:35
RCUS Arcus Biosciences, Inc. 29 Jan 2024 1 +$319,999,995 4 10%+ Owner 31 Jan 2024, 17:00
ACLX Arcellx, Inc. 28 Dec 2023 0 $0 3 10%+ Owner 28 Dec 2023, 17:09
HOOK HOOKIPA Pharma Inc. 20 Dec 2023 0 $0 3 10%+ Owner 22 Dec 2023, 16:07
ASMB ASSEMBLY BIOSCIENCES, INC. 16 Oct 2023 0 $0 3 10%+ Owner 25 Oct 2023, 19:15
RCUS Arcus Biosciences, Inc. 28 Jun 2023 1 +$19,452,600 4 10%+ Owner 30 Jun 2023, 15:12
KLRS Allovir, Inc. 27 Jun 2023 1 +$10,990,762 4 10%+ Owner 28 Jun 2023, 17:17
KLRS Allovir, Inc. 28 Jul 2022 0 $0 3 10%+ Owner 05 Aug 2022, 17:45
HOOK HOOKIPA Pharma Inc. 15 Feb 2022 0 $0 3 10%+ Owner 17 Feb 2022, 13:45